Bincy P. Abraham, MD

  • 2037 Citations
  • 19 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Bincy P. Abraham, MD, MS, is an associate professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.

Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.

Research interests

Dr. Abraham is a principal investigator and coinvestigator in several key clinical trials. As author or coauthor, Dr. Abraham’s work has been published in peer-reviewed medical journals including Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases.

Research Area Keywords

  • Digestive Disorders

Free-text keywords

  • Crohn's disease
  • Pregnancy & inflammatory bowel disease
  • Transition of care in inflammatory bowel disease
  • Ulcerative colitis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Antibiotics and probiotics in inflammatory bowel disease: When to use them?

Abraham, B. & Quigley, E. M. M., Jan 1 2020, In : Frontline Gastroenterology. 11, 1, p. 62-69 8 p.

Research output: Contribution to journalReview article

  • 2 Scopus citations
  • The microbiome and inflammatory bowel disease

    Glassner, K. L., Abraham, B. P. & Quigley, E. M. M., Jan 2020, In : Journal of Allergy and Clinical Immunology. 145, 1, p. 16-27 12 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study

    Glassner, K., Oglat, A., Duran, A., Koduru, P., Perry, C., Wilhite, A. & Abraham, B. P., May 1 2020, In : Journal of Digestive Diseases. 21, 5, p. 264-271 8 p.

    Research output: Contribution to journalArticle

  • Nanotechnology in the treatment of inflammatory bowel disease

    Giron, F., Pastó, A., Tasciotti, E. & Abraham, B. P., Dec 1 2019, In : Inflammatory bowel diseases. 25, 12, p. 1871-1880 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations